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The application of computer vision for COVID-19 diagnosis is complex and challenging, given the
risks associated with patient misclassifications. Arguably, the primary value of medical imaging for
COVID-19 lies rather on patient prognosis. Radiological images can guide physicians assessing the
severity of the disease, and a series of images from the same patient at different stages can help to
gauge disease progression. Hence, a simple method based on lung-pathology features for scoring
disease severity from Chest X-rays is proposed here. As the primary contribution, this method shows
to be correlated to patient severity in different stages of disease progression comparatively well
to other existing methods. An original approach for data selection is also proposed, allowing the
simple model to learn the severity-related features. It is hypothesized that the resulting competitive
performance presented here is related to the method being feature-based rather than reliant on lung
involvement or compromise as others in the literature. The fact that it is simpler and interpretable
than other end-to-end, more complex models, also sets aside this work. As the data set is small,
bias-inducing artifacts that could lead to overfitting are minimized through an image normalization
and lung segmentation step at the learning phase. A second contribution comes from the validation
of the results, conceptualized as the scoring of patients groups from different stages of the disease.
Besides performing such validation on an independent data set, the results were also compared with
other proposed scoring methods in the literature. The expressive results show that although imaging
alone is not sufficient for assessing severity as a whole, there is a strong correlation with the scoring
system, termed as MAVIDH score, with patient outcome. The method has the potential to help
physicians rating and following disease progression in COVID-19 patients, especially when making
decisions on resource-scarce environments.
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1 Introduction
COVID-19 remains an imminent threat to society with many countries experiencing a severe second wave of the virus
Giacomo et al. [2020]. One widely documented characteristic of COVID-19 infection is the wide range of symptoms
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range of symptoms including fever, cough, fatigue, headache and diarrhoea Huang et al. [2020] to severe pneumonia
requiring admission to ICU with mechanical ventilation Guan et al. [2020]. Reported case-fatality rates vary from 1%
to greater than 7%, usually due to respiratory failure Vincent and Taccone [2020]. Fatal cases tend to progress rapidly,
particularly in the case of elderly patients where the average survival time after admission can be as low as five days
Wang et al. [2020]. Given this wide range of patient symptoms and potentially rapid progress to death in severe cases, it
is imperative that a patient’s condition be objectively tracked for severity so that scarce critical care resources may be
efficiently deployed to improve patient outcomes.
Whilst care in modern ICUs will result in death rates towards the lower end of the range, life-sustaining therapies will,
in practice, be limited by lack of personnel, beds or materials and equipment. There is an emerging body of evidence
showing a close association between greater mortality and overwhelmed healthcare infrastructures Ho and Neo [2020].
This limitation of resources leads clinicians to make prognostic decisions based on criterion such as old age, fragility
and comorbidity that can lead to the death of patients with poor prognosis in favour of patients with better progression
outlook Vincent and Taccone [2020]. Understanding patient prognosis is therefore critical to patient outcomes at both
an individual and group level.
Pathological multivariate scoring has been shown to be predictive of COVID-19 patient admission to ICU and death
Allenbach et al. [2020], Fan et al. [2020]. This approach requires the collection of pathology data points such as CRP
levels, lymphocyte counts, platelet counts, interleukin, and procalcitonin levels. Although effective, this approach may
not be practical in a triage situation, since the collection of necessary pathological data points is both resource-intensive
and time-consuming. Having a more accessible indicator for the severity progression would therefore be desirable and
potentially useful.
Chest medical imaging has proven to be useful in managing more serious COVID-19 infections since progressive
respiratory failure caused by massive alveolar damage is the main source of COVID-19 mortality Xu et al. [2020].
In particular, Chest X-rays (CXR) and Computed Tomography (CT) imaging are useful tools in the management of
moderate to severe COVID-19 cases since these methods help clinicians to establish a baseline pulmonary status and
identify underlying pulmonary conditions that may contribute to the patients’ risk, as well as assessing COVID-19
progression Rubin et al. [2020]. The CXR imaging mode has the advantage of being less expensive per scan in
comparison to CT Flores et al. [2017] and available as portable apparatus that is easier to disinfect than CT equipment
(which is typically fixed in a dedicated radiology room) Wong et al. [2020]. Although not as accurate as CT or
Ultrasound Horry et al. [2020], the sensitivity of CXR imaging increases over the course of COVID-19 infection with
serial CXR imaging, especially after day 6 of symptom onset Stephanie et al. [2020].
One approach to COVID-19 severity and progression scoring is the automated or semi-automated analysis of medical
images taken over consecutive periods. Several such scoring techniques appear in the literature for both the CXR
and CT imaging modes Wasilewski et al. [2020], Yang et al. [2020]. These techniques typically divide the medical
image into geographical regions with each region manually assessed by radiological staff according to specific criteria.
Semi-qualitative manual scoring of CXR has been shown to have prognostic value for COVID-19 progression in low,
moderate/high and highly severe cases corresponding to scores 1, 3 and 4 Baratella et al. [2020], Borghesi and Maroldi
[2020]. Notably, there is no indication that these methods are reliable for moderate cases outside of this score range.
Since the manual interpretation of medical images is a highly specialized and resource-intensive skill, many researchers
have investigated the utility of deep learning systems in determining a COVID-19 severity score. Such systems have
proven to be successful in quantifying COVID-19 lung compromise at a point in time Blain et al. [2020], Cohen et al.
[2020a], sometimes with good correlation between results from the CXR and CT imaging modes Amer et al. [2020].
Automation of the semi-qualitative approach has been proposed with results that are promising but leave much room for
improvement, in part due to the difficultly associated with establishing the ground truth to such methods due to human
radiological interpretation Signoroni et al. [2020]. The use of deep learning can have limited applications in medical
use cases when used as support for decisions that affect a patient’s clinical outcome because of their non-explainable,
black-box nature. One popular technique for interpretation on convolutional networks is the saliency map, which
provides a heatmap overlay of network attention calculated on a gradient basis Simonyan and Zisserman [2014].
Nevertheless, there are still serious concerns as to whether saliency mapping techniques accurately reflect trained model
parameters Adebayo et al. [2018] since they do not have shown to be robust under rigorous examination in the context
of medial imaging Arun et al. [2020].
Given the issues of assessing disease progression and explainability, this work presents an interpretable, fully-automated,
CXR severity scoring for COVID-19 named MAVIDH (Machine Vision and Digital Health research group) score. The
method uses machine learning techniques to extract semantic features from the CXR and score COVID-19 patients
based on a particular selection of ICU-admission data. The method is validated against an independent data set and
through a comparison with other existing works. Such a comparison is made in a proposed framework comprised of
images from patients in different stages of disease progression that allows judging the score based on the different
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expected severity from particular groups. The analysis shows that there is a relationship between CXR features and
patient stratification. It is envisaged that this research may lead to the development of analytic tooling that will help
clinicians stratify COVID-19 patients to achieve better outcomes while being valuable in assisting clinics in managing
resource requirements relating to ICUs.
2 Related work
The amount of papers proposing computer vision techniques and other similar efforts to assist the control of the
COVID-19 pandemic has established a trend in research Ulhaq et al. [2020], Manna et al. [2020]. Due to the popularity
and accessibility of deep learning algorithms for classification tasks, one can find several works proposing algorithms for
COVID-19 diagnosis based on radiological images. Nevertheless, there is a constant concern by physicians and experts
that such methods have little practical use due to the potential bias, uncertainty, and consequential risks of relying
on such algorithms for a diagnosis Wynants et al. [2020], Bachtiger et al. [2020]. There are efforts to mitigate such
problems like segmenting and aligning the lung images, which helps Tartaglione et al. [2020], Rabinovich et al. [2007]
but does not solve the diagnostic concerns. Some therefore argue that the most plausible fair use of such technologies is
in gauging disease progressions and severity Cohen et al. [2020b].
Regarding disease severity assessment, there have been a number of efforts to produce multivariate COVID-19 risk
stratification scores Wynants et al. [2020]. Not all of these methods are computer-vision based, and some rely on
potentially onerous data to estimate the disease severity. The access to medical imaging such as CXR and CT,
represents an alternate method of COVID-19 patient risk stratification, which is to use medical images to quantify lung
abnormalities. X-rays, in particular, are flexible and inexpensive technology that could help physicians assess disease
progression and severity. A particularly popular approach for using CXR in disease severity is the Brixia score Borghesi
and Maroldi [2020], which is a method that uses a heuristic scoring system to quantify a severity score for COVID-19
pneumonia. It can be seen as a semi-qualitative assessment of lung disease by ranking pulmonary involvement over
upper, middle and lower zones per lung on an 18 point severity scale. The Brixia score is an example of what will
be referred to here as a lung-involvement score since it tries to estimate to what extent the lungs are compromised by
pathologies like lesions and opacities.
Works using Brixia-like scores in both automatic Amer et al. [2020], Signoroni et al. [2020], Cohen et al. [2020a] and
non-automatic Allenbach et al. [2020], Baratella et al. [2020] approaches can be found in the literature. The intricate
end-to-end methods such as Amer et al. [2020] names their score as ‘Pneumonia Ratio’, for example; others like Cohen
et al. [2020b], Blain et al. [2020] base its severity score on features named Opacity and Geographic extension. These
methods seem to have some predictive value, but most rely on the extension of lung involvement and scores given
by human experts, which they try to regress. In this paper, however, a hypothesis tested is that a method that does
not rely on lung involvement and expert labelled data but rather on features from known lung pathologies and data
selection from patients in different stages of the disease can work well at tracking disease progression. This testing
is performed by comparing the results of such a method with other existing works. However, the comparison is only
possible with other methods that fit the same definition as this one: automatic, computer-vision based, using CXRs to
produce the severity score, and that also had code available to be implemented in the same comparable framework. To
those requirements, only two other works were found fitting such description,
Cohen et al. Cohen et al. [2020a] employed three blinded radiologists to stage disease severity using the extent of
lung involvement and degree of opacity to establish ground truth. Then, a deep convolutional neural network, trained
on a number of public datasets covering 18 common radiological findings, was used as a feature extraction layer for
COVID-19 CXR images. The features were then sequentially connected to a linear regression layer to predict the extent
of lung involvement and degree of opacity to labels from experts as ground truth. The results showed relative fair
measures for the regression with a mean absolute error of 1.14 for the geographic extent score and only 0.78 for the
lung opacity score. Still, no validation on patients from different stages of disease progression was performed.
Taking a different approach to Cohen, Signoroni et al. Signoroni et al. [2020] used a large clinical dataset of 5000 CXR
images to train a deep learning-based implementation of the semi-quantitative Brixia score. The results showed that it
achieved an accuracy equivalent, or better than human radiologists with arguably greater consistency. After segmenting
and aligning lung fields from source CXR images, a preprocessing pipeline was implemented to equalize and denoise
the dataset before using these images to train variations of a ResNet-18 based CNN (BS-Net). The network showed
comparable performance against an independent COVID-19 dataset in portability studies indicating potential usefulness
in other clinical settings.
The work proposed here has comparably slightly less complexity than Signoroni et al. [2020], which is fully end-to-end,
but it is a bit more intricate than Cohen et al. [2020a], which does not use lung segmentation as a preprocessing step.
The few degrees of lesser complexity allows the method presented here to be more interpretable then more complex
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alternatives as it uses a specialized CNN to extract features but, as in Cohen et al. [2020a], uses such features in simpler
but potentially more robust and explainable learning methods.
3 Data and methods
3.1 Data sets
The main aspects of this work are the two data sets of X-rays images from different sources and the original methodology
for severity scoring based on low-complexity, semi-interpretable, machine learning. The critical data set for assessing
the hypotheses presented here was recently proposed and contained a set of multiple-instances images of patients at
different stages of the disease Winther et al. [2020]. By having samples of images at different moments of disease
progression from the same patient, this data set can be seen as a source of potential insights regarding the role of X-rays
in assessing disease severity. Differently from most published in the literature up to date, this data set has rich metadata
containing the distance (in days) from when the image was taken to the hospital and ICU admission. It is the most
detailed data in this respect, to the best of our knowledge. Given the authors’ affiliation to Hannover Medical School
in Germany, this data set will be referred here as ‘Hanno’. At no stage, this data set was used to learn the methods
presented here; the Hanno data set was used only for validating the proposed hypotheses and comparing results to other
methods. The other data set, used for learning the features relevant to the disease severity, is the popular set of X-ray
images by Cohen et al. Cohen et al. [2020b], referred here by the first author’s name. The Cohen data set has been used
in many works in the literature focused on disease diagnosis, but much less in progression and severity scoring. The
data set has limited metadata on the ICU admission in regards to the moment in time of when the image was taken but
has some potentially relevant categorical classes concerning the stage and patient severity.
In short, the Hanno data set comes with 234 images, but the quality is much varied. Cleansing is performed on images
where the lung field is not clearly visible, and a significant part is excluded. In total, 154 images resulted from such a
selection. From these, 54 are images from patients that were not admitted in ICU, while the remaining 100 images are
from patients taken in different stages of disease progression. This set of images is used in the same conditions for all
the comparison to other methods and validation. Although it usually only contains a few images from the same patient,
the rich metadata with the offset in days from key moments of disease progression can be used to group patients in
defined periods of progression so an original validation approach can be adopted; more on the grouping method in the
following subsections.
The Cohen data set is a somewhat popular set of X-Ray images, first announced in April 2020. Although it was first
described in March 2020, it has more than 200 citations, 2000 favourites in Github, and many implementations. A
significant part of citing works use this data set to address the diagnosis problem. Nevertheless, the diagnosis of COVID
through imaging is a delicate problem, and its solution should present high robustness to risk in order to be useful. A
number of authors have written on the challenges of such a use Arun et al. [2020], DeGrave et al. [2020], Wynants et al.
[2020] with some pointing that probably the most promising use of X-rays would be at assessing disease severity and
progression in a prognostic approach Cohen et al. [2020b], Manna et al. [2020]. With this in mind, this methodology
processes a different use of the data set, where classes of patients with different ICU-related outcomes are adopted. By
using this approach, it is hoped that the learned model will learn a reasonable probability estimator of patient outcome
that could be used as a score. In all, after selecting the images with reasonable quality where the lungs and its features
were visible and fitted our particular criteria for the patient stage, 100 images were selected. These were previously
validated by the authors of this paper in a work describing how a similar approach could point to potentially relevant
semantic features correlated to ICU outcome Gomes et al. [2020].
Regarding model selection, it is worth further commenting on the major factors to the methodological decisions
proposed here, which is to avoid overfitting and prioritize interpretability. The main reasons for that are two-fold: (1) the
data sets used are limited, and one should therefore minimize the risk of overfitting, and (2) differently from methods
using end-to-end deep learning for X-ray analyses, interpretability can be much valuable in subjects like healthcare. The
over-cautious care for overfitting leads to the choice of low-complexity methods (low Vapnik–Chervonenkis dimension),
which are also usually more interpretable. The feature extraction role is performed by a deep, pre-trained specialized
CNN, but the regression and classification results are given by a simple logistic regression model. Such a specialized
CNN was trained to detect common lung pathologies with a combination of large data sets of tens of thousands of X-ray
images. Its outputs are features learned to have semantic meaning, i.e., each of them can be seen as probability scores
of different lung pathologies. It is thus more interpretable in the sense that the features are real pathology scores, and
one can see how much weight is given to each feature in the subsequent severity scoring. This construction relates
deeply with one of the hypotheses discussed here, which is that features representing specific pathologies in the lung
may correlate better with the severity of symptoms than methods that estimate lung compromise, thus resulting in a
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Figure 1: Training and validation curves from the lung segmentation network — Skip U-Net.
more realistic scoring. Since the feature extraction method is performed by such a deep, specialized network, one can
say that it does fit into the learning paradigm known in the literature as transfer learning Shermin et al. [2019].
3.2 Feature extraction pipeline
Before extracting the features with such specialized CNN, the selected images are fed through a preprocessing pipeline,
which has the goal of normalizing and reducing potential artifacts that could lead to biases in learning. Such a pipeline
comprises sequential blocks with defined tasks: histogram equalization, lung segmentation, and cropping of the lung
area. All these are done automatically with processes that share the same parameters for all images. Histogram
equalization is the main normalization, and it is applied at the beginning and end of the pipeline. At the input, the
normalization is standard, and it equalizes the pixel distribution so they are not concentrated in a small range, which
could induce bias. Before the output, an image normalization technique called Contrast Limited Adaptive Histogram
Equalization (CLAHE) is applied, which could be seen as a local histogram normalization. This technique is used to
highlight the small local pathology features, so their contrast could be improved.
The lung segmentation step is subsequently applied to the images in the preprocessing pipeline. As data sets are
limited, and there are many bias-inducing features in the images like bones, medical devices, and letters, segmenting
the lungs can be seen as increasing the signal-to-noise ratio for the learning algorithm. This practice is corroborated in
previous studies Rabinovich et al. [2007] in the literature where one can also find comprehensive reviews on lung area
segmentation Candemir and Antani [2019]. Earlier works on lung segmentation presented dice similarity scores up to
0.989 Hwang and Park [2017]; a much simpler approach using the U-Net architecture was also proposed, achieving
0.974 Ronneberger et al. [2015]. The latter was trained on the JSRT dataset Shiraishi et al. [2000] consisting of 385
CXR images with gold-standard masks. In this work, we present a deep learning-based lung segmentation that surpasses
such scores.
The lung segmentation network learned here is a variation of the U-Net architecture using skip connections with a
ResNet backbone He et al. [2016]. This adoption is in contrast to the U-Net trained on simple convolutional stacks
with max pooling and VGG architecture Simonyan and Zisserman [2014]. The authors hypothesized that the skip
connections allow the features in earlier layers to be reused, thereby increasing the performance of the segmentation.
Such a network design achieved a maximum validation dice similarity coefficient of 0.988 at epoch 93, as illustrated in
Fig. 1, which depicts its learning curves. The performance boost was probably also achieve given the use of additional
data sets adding up to 1185 CXRs samples Jaeger et al. [2014].
The pipeline then ends with lung-area cropping, which is a combination of closing of the masks and cropping any pixels
outside their area. The closing of the masks helps to get rid of any artifacts escaping the lung segmentation network,
and it is performed by a combination of morphological closing, contour and flood filling. The cropping has a desirable
effect of normalizing the images for lung size; the lung area sometimes occupies only part of the image, either by the
size the extent that the image covers of a patient or by factors like the size of the person or age. Examples of images in
different stages of the preprocessing pipeline are illustrated in Fig. 2.
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(a) (b) (c)
Figure 2: Chest X-Ray images in different stages of the pre-processing pipeline. a) Original images with different
contrast and histogram. b) Segmented lungs without the normalization techniques. c) Images with lungs segmented and
normalization applied.
3.3 Learning and validating the progression score
The methodology framework can be divided into two parts: learning and validation. The fact that each one of these
parts is performed with data sets from different sources helps to attest the method’s ability to generalise. However, a
meaningful result can only be achieved if overfitting can be limited, especially given the number of samples in the
Cohen data set. Regarding the use of such a data set in the learning stage, one of the original ideas presented here is
that, different from other methods that use it in a classification approach with ‘COVID’ and ‘Non-COVID’ classes,
this methodology filters the metadata in particular classes: patients that were admitted to ICU but had the image taken
before admission (‘future icu’) and patients that recovered without intensive care (‘not icu’). This filtering is particularly
interesting because the first class is populated by samples of patients that, despite not being present in ICU at the time
the image was taken, were eventually later admitted. Their images could potentially present insightful information of
predecessor features to disease severity.
At the learning stage, the methodology using the semantic features for progression scoring is performed by first
extracting the semantic features (specialised CNN), standardising them, and fitting a logistic regression model to classify
the data in one of two mentioned classes (‘future icu’ and ‘not icu’). If the accuracy of the classifier showed it to
have relevant invariance to the classes, one can hypothesise its estimated class probability (output from the logistic
regression) could be correlated to the patient’s severity state. That would not be necessarily surprising since such the
classifier was learned to attempt to predict if a particular patient, given their X-ray, will eventually be admitted to ICU
or not. However, it is also not surprising that one would be sceptical of the validity of such a progression score. This
potential concern is the reason for also proposing an original validation approach and comparison to other methods in
the literature.
The original validation approach proposed here comprises two parts: (1) a heuristic method for grouping scores from
patients’ images taken in similar stages of symptom progression, and (2) a comparison of the group scoring to other
methods in the literature by implementing their code in the Hanno data set. It is worth noting that the grouping in the
first step is only possible because, differently from Cohen (used for training), the Hanno data set contains rich metadata
on the offset (number of days) from specific moments in the disease progression. The proposed heuristics here is to
group X-ray images from 4 distinct periods or classes of patients:
• Group 1: Images from patients not admitted to ICU.
• Group 2: Images from patients in the vicinity (between 1 day before or after) of ICU admission.
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Figure 3: Graphical abstract of the methodology. Images taken from the Cohen data set are particularly selected,
processed and used for learning a severity scoring model. The images from the Hanno data set are processed and scored
by the learned method and by other two from the literature. The assessment of the results is performed via a grouping
method also proposed here.
• Group 3: Images from patients currently in ICU (between 1 day past ICU admission and 1 day before ICU
release).
• Group 4: Images taken in the vicinity (in between 1 day before or after) of ICU release.
By the definition of these groups, one can hypothesise that despite the actual value of the score, it should respect a
particular trend between groups to have at least minimal significance. For example, Group 1 and 4 should have the
lowest scores on average, with patients that did not go to ICU (Group 1), being even lower than patients in the vicinity
of ICU release (Group 4). Moreover, one should expect that Group 2, populated by images of patients in the vicinity of
ICU admission, to have the high scores on average, as well for patients in Group 3 (currently in ICU).
Although following the expected trend is not definite evidence of the score validity, it indeed corroborates the hypothesis
that it is any indicator correlated to disease severity. The contribution is reinforced if such a scoring method presents
yet competitive results to other methods in the related literature. This point should be highlighted by noting that the
data sets for training and validation come from different distributions, and any resulting validation should be more
dependable than trivial train-test splits on the same data set. It is also important to note that the comparison to other
methods was only possible because the authors made their code and neural network weights available. This initiative is
praiseworthy and should be incentivised since it can increase the progress rate in such an urgent field. To better clarify
how the pieces of the methodology work together, Fig. 3 presents the synthesised methodology in diagram form.
4 Results
4.1 Observational findings
The close inspection of the data sets given by the experience from developing this methodology generated insights
on the potential role of X-rays to score disease severity. Although it is a somewhat trivial notion that X-rays will not
translate all the information to a definite score the disease progression, some discrete insightful examples can illustrate
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(a) Example of a case where the images loosely correlate to the develop-
ment of the disease.
(b) Example of a case where the quality of the images is counter-intuitive
to the actual disease progression.
(c) Example of a case where the images taken in very distinct moments
do not show evident visual differences.
Figure 4: Noticeable cases of images taken from patients in distinct moments of their disease progression.
some of the limitations; the authors have not encountered such observations in other works, especially regarding the
X-ray diagnosis-related literature. These honest illustrations are not necessarily unexpected since other comorbidities
and patients’ conditions will significantly affect the severity of their symptoms. Some notable cases are depicted in Fig.
4 as examples that correspond (Fig. 4a) or not (Fig. 4b-4c) to the expected stages of the disease.
Given such findings, the question then becomes to what extent X-rays can track the severity in the disease progression.
This question, as the primary motivation of this paper, is important because although other methods in the literature
rate the severity of lung damage with features like opacity and geographic extension, they do not attest if such scores
actually correlate to the progression of the patients’ symptoms or need for intensive care. The following results from
grouping the patients in similar stages and comparing their score is set to address this issue.
4.2 Scoring
As a preamble to the results, it is worth noting a crucial aspect that makes this approach original, which is the data
selection for learning. The scoring method itself is simple and direct, but as in every other problem, data is still
paramount; model complexity is inconsequential when the labelled data does not present the information one needs.
As it will be soon demonstrated, having a simpler but interpretable method also has considerable advantages. The
main difference in the methodology adopted in data selection is the fact that images were not classified in ‘COVID’ vs.
‘non-COVID’, for example. They also did not have the lesions previously visually rated by humans in an attempt to
model the intensity of score of lung damage. The hypothesis here is that some features may be more important than
others in predicting severity than the overall area of involvement and that a specialised neural network could capture
such information. The samples were therefore classified in two classes: images taken from patients previously to their
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(a) (b)
Figure 5: Confusion matrix from the training data set, Cohen (a), and from the validation data set, Hanno (b).
ICU admission, and patients that were not admitted to ICU but were symptomatic enough to have their images taken.
Both classes being patients with COVID. A classifier trained on these two binary classes will approximate the task of
rating the probability that a patient will end up needing intensive care or not.
4.3 Separability
Before using the selected classes as a scoring model, one should first attest if such particular classes are separable.
Given the limited data set size, one should take extreme care to constrain overfitting and thus choose a simple classifier
not simply to shatter the data set. Since a simpler classifier means a simpler set of admissible functions relying on fewer
features, they have the advantage of being more robust with a stronger chance of generalising. As previously mentioned
for scoring, attesting the separability between classes will also be done by using the Cohen data for fitting the classifier
and the external (Hanno) data set for validation.
The classifier chosen, given the model selection criteria mentioned above, was a shallow and limited decision tree. The
only parameters changed from the scikit-learn library Pedregosa et al. [2011] defaults were the maximum depth of the
tree to 3, and the minimum leaves in a node to 10. This setting aggressively limits the ability of the thee to branch into
nodes based only on a few observations, consequently limiting overfitting. In fact, the following separability figures
resulted from a decision tree with only 5 nodes (5 from the 18 features). The in-depth work of using shallow decision
trees for analysing the semantic features relevant for classification was done in a previous work by the authors Gomes
et al. [2020] and will thus not be discussed in detail here.
Fitting the shallow decision tree led to a classification accuracy of 82% on the training data (Cohen). For cross-validation
in a leave-two-out scenario, the resulting accuracy was 73%. Note that although being from the same data set, the
accuracy resulted from cross-validation does not include data used in training. It should be noted that validating on the
Hanno data set it is not done in the strict sense. This data set does not have metadata on if the patient was eventually
admitted in ICU in the future as does Cohen, but it has labels on which images are from patients in ICU or not. Such
validation is then more related to the ability to detect severity than predicting the outcome. Having noted that, the
resulting accuracy on the Hanno data set was 77%. Both confusion matrices, from validating on the Cohen and Hanno
data sets are illustrated in Fig. 5. The accuracies and confusion matrices show that the data are not entirely separable,
but it also indicates that there is a correlation between these 5 features (’Effusion’, ’Consolidation’, ’Pneumonia’,
’Fracture’, ’Pleural Thickening’) and symptom severity.
4.4 MAVIDH score assessment
As stated in the methodology, the assessment of the MAVIDH score model was done by creating a method for grouping
the patients in specific moments of symptom progression. As the score only approximately correlates with the patient
severity, the grouping method helps to assess the correlation to the expected trend by comparing different statistical
metrics from each group. In total, there were 57 images from patients not admitted in ICU, 37 in the vicinity of being
admitted, 112 images of patients in ICU, and 31 in the vicinity of being released.
Trained with the particular proposed labels, the binary regression model outputs a probability given by the logistic
function, which is used here as the MAVIDH severity score. Since every image has a respective score, the box and
whisker plot was chosen to illustrate the different statistical metrics from each of the groups in Fig. 6. The box plot
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Figure 6: Group score box plot of the method proposed here (MAVIDH score).
presents some worth mentioning points regarding the agreement to the expected trend, like the fact that the upper
quartile of patients that were not in ICU (0.22) was smaller than all the other groups (0.345, 0.370, and 0.324). The
fact that patients in the vicinity of ICU admission have more spread and higher median score (0.496) is also somewhat
expected as these patients should be close to or already presenting severe symptoms. In the group of patients in ICU, the
interquartile range consolidates at a higher level and tighter range (0.203) as compared to others, showing that severity
is more consistent between images. The patients in the vicinity of being released have a slightly smaller median than
other ICU-related groups and much less distance between the upper quartile and maximum value than other groups.
4.5 Comparison with other methods
The method presented by Cohen et al. [2020a] has an interesting similarity with the one presented here, which is that
both use the same feature extraction network. However, as Signoroni et al. [2020], it tries to regress the score based on
expert labelled data. In the case of Cohen et al. [2020a], the task is generate scores based on opacity and geographic
extension labels rather than tracking patient severity. It should be noted that the following comparisons and commentary
do not concern the method’s quality or ability to assess these features; they are rather related to their correlation to
patient severity in the groups designed here.
Both the opacity and geographic extension were calculated for all images in the Hanno data set using the author’s code.
The opacity feature range between 0 to 6, while the geographic extention from 0 to 8. As seen in the Fig. 7, they do
not necessarily track the progression in an expected trend. Differently from the method proposed here, the range of
score for ‘non-ICU’ patients are much less concentrated at a lower level and spam most of the range of other groups.
Moreover, the group that has the highest and consolidated score is the one of patients in the vicinity of release, which is
contrary to the expected trend.
The second method to be compared presents a strong case for severity scoring. As the method being proposed here, it
integrates lung segmentation but also performs alignment and rotational invariance. It is not, however, trained with
severity labels but with data labelled by humans on lung comprise. The scores presented in Fig. 8 were calculated by
using the code and network weights kindly shared by the authors. Resulted from trying to regress scores on sections of
the lung in the Brixia-score framework Borghesi and Maroldi [2020], the output score ranges from 0 to 18, as it rates six
different parts in scores from 0 to 3. As illustrated by the resulting box-plot scores, it is somewhat consistent at tracking
the expected progression trend. Some differences from the score results from the work here can be noticed. For one, the
fact that for patients not admitted to ICU, the scores are not all concentrated at a lower level. The upper quartile is not
smaller than all the other groups’ lower quartile, and the consolidation of score happens in the group in the vicinity of
admission rather than in the group confirmed to be in ICU. However, the scores do present a significant trend, which in
the same direction as this work, attest the existence of some significance of X-ray severity scoring to help assess patient
symptom severity. The authors of this scoring method should be praised since their results show some significance at
tracking patient severity progression, even though that was not exactly the learning task. Nevertheless, it must be noted
that this method is entirely end-to-end with interpretability reliant only on gradient maps.
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(a) (b)
Figure 7: Group score box plot of the a) Opacity and b) Geographical extension features from Cohen et al. [2020a].
Figure 8: Group score box plot from the method presented in Signoroni et al. [2020].
4.6 Examples of scoring in the validation data set
As a result of applying the scoring method presented here, Figs. 9-11 illustrate the scores from a particular patient
through time with their segmented X-rays. The horizontal dimension of the images represent the days from the hospital
admission, and a dashed line is plotted through the scores to show tendencies. Most patients had only a few images; the
following illustrations are some exceptions.
The first, illustrated in Fig. 9, was one of the few patients that had the first X-ray taken multiple days before the hospital
admission. The scores and X-rays show that signs of severity were present much before the ICU admission, and it
improved after intensive care. The second, shows a score getting progressively worse for a patient that was in ICU for
many days. As shown in Fig. 10, the last X-ray image from this patient was taken at yet 23 days from ICU release,
meaning that the patient was still in severe conditions and needed more time to recover. Lastly, Fig 11 shows an example
of a relatively ambiguous result where similar images appear to have distant scores, attesting for the limitations of the
method.
As the grouping analysis images have shown, despite the method chosen, there is probably much space for improvement
in a potential COVID-19 disease severity scoring. The goal here was to show evidence that there is a probable relevant
correlation in the information present in X-ray images to the severity of COVID patients rather than claiming an optimal
score. It must be noted that such results were achieved with very limited data sets, and the fact that it was validated
through different data sets should add to its expressivity. The authors hope to leverage better and bigger data sets to
continue the investigation on the important features for disease severity that could help physicians to analyse medical
imagining while assessing the patient’s progression.
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(a)
(b)
Figure 9: Patient no. 4 scoring a), and segmented X-rays b).
(a)
(b)
Figure 10: Patient no. 9 scoring a), and segmented X-rays b).
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(a)
(b)
Figure 11: Patient no. 13 scoring a), and segmented X-rays b).
5 Conclusions
The present work has focused on presenting a feature-based, semi-interpretable, COVID-19 disease severity scoring
and comparing its significance to other methods in the literature. The scoring method comprises a feature extraction
pipeline with image normalisation, lung segmentation, and feature extraction by a specialised network trained to extract
semantic features related to lung pathologies. The features were used in a logistic regression model to output the
estimated probability of a patient going severe. One notable contribution was the data selection for such learning, which
is filtered and labelled in a specific way so the model can learn the severity-related information. Such comparison is
performed through a grouping methodology applied on a data set (Hanno) with metadata regarding the hospital and ICU
admission offset. The analysis showed that the MAVIDH score proposed here had advantages at tracking the expected
trend of the conceptualised groups. This is not to say that other methods are deficient since they were not trained
for this task but rather to regress overall rate lung compromise. The results here attest the existence of a correlation
between the developed score with patient severity through the disease progression. Although such a score does not
perfectly correlate to severity, seen by the variance in the groups, the authors believe that it is a notable result given the
limited data and the fact that presents comparable results to other more complex methods in the literature. It comprises
a sensible, simple, and reasonably robust severity assessment support for a much urgent problem. The authors hope to
improve this solution further with the availability of more high-quality and detailed labelled data in the near future.
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